- cafead Feb 07, 2024 at 11:52: AM
via Japan’s Kyowa Kirin has commenced a Phase II clinical trial of tivozanib eye drops (KHK4951) for diabetic macular oedema (DME), with the first subject now enrolled.
The trial aims to assess the safety and efficacy of KHK4951 in patients with DME across multiple countries, including the US, Japan, Australia, and South Korea.
article source
The trial aims to assess the safety and efficacy of KHK4951 in patients with DME across multiple countries, including the US, Japan, Australia, and South Korea.
article source